These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 1247997

  • 1. Pituitary role in the growth of metastasizing MRMT-1 mammary carcinoma in rats.
    Harada Y.
    Cancer Res; 1976 Jan; 36(1):18-22. PubMed ID: 1247997
    [Abstract] [Full Text] [Related]

  • 2. Increased incidence of mammary tumors in the female rat grafted with multiple pituitaries.
    Welsch CW, Jenkins TW, Meites J.
    Cancer Res; 1970 Apr; 30(4):1024-9. PubMed ID: 5504344
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
    Gandilhon P, Mélançon R, Djiane J, Kelly PA.
    J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
    [Abstract] [Full Text] [Related]

  • 5. Influence of insulin administration on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in intact, oophorectomized, and hypophysectomized rats.
    Heuson JC, Legros N, Heimann R.
    Cancer Res; 1972 Feb; 32(2):233-8. PubMed ID: 5058184
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of various oncogenic agents on tumor-producing capabilities of series D BALB-c mammary nodule outgrowth lines.
    Medina D, DeOme KB.
    J Natl Cancer Inst; 1970 Aug; 45(2):353-63. PubMed ID: 4324612
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of prolactin-induced mammary cancer in C3Hf (XVII) mice with the trans isomer of bromotriphenylethylene.
    Drosdowsky M, Edery M, Guggiari M, Montes-Rendon A, Rudali G, Vives C.
    Cancer Res; 1980 May; 40(5):1674-9. PubMed ID: 6245799
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Induction of metastasizing carcinoma in rats and their biological characteristics.
    Harada Y.
    Acta Pathol Jpn; 1975 Jul; 25(4):451-61. PubMed ID: 170787
    [Abstract] [Full Text] [Related]

  • 17. Hyperplastic lesions of mouse mammary glands after treatment with 3-methylcholanthrene.
    Faulkin LJ.
    J Natl Cancer Inst; 1966 Feb; 36(2):289-97. PubMed ID: 4286277
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prolactin-dependent rat mammary cancer: a model for man?
    Pearson OH, Llerena O, Llerena L, Molina A, Butler T.
    Trans Assoc Am Physicians; 1969 Feb; 82():225-38. PubMed ID: 5375151
    [Abstract] [Full Text] [Related]

  • 20. Effect of hormone stimulation, dose, and time of administration of carcinogen on carcinogen-induced mammary tumors from preneoplastic nodule outgrowths.
    Medina D.
    J Natl Cancer Inst; 1971 Apr; 46(4):909-16. PubMed ID: 5573775
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.